🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 928251107
- Market Cap
- Micro Cap
- IPO
- 2/17/2021 · $10.00/share
Business: Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax is developing branded pharmaceutical product candidates for pain management by using advanced technology in an effort to enhance patients' quality of life.
Company Contact
- CEO
- Anthony P. Mack
- CFO
- Vinay Shah
- Headquarters
- 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312
- Phone
- 610-727-4597
- Investor Relations
- Betsy Brod, Affinity Growth Advisors · 212-661-2231 · betsy.brod@affinitygrowth.com